Cell pellets were resuspended in HPLC-grade water and vortexed or sonicated to disrupt cell membranes to obtain a homogeneous suspension. Samples were extracted using 0.25 ml quality control, plasma blank or sample in 0.75-2.0 mL HPLC-grade water, 0.1 ml internal standard (IS) solution (75.0/225 pg/mL d 3 -T/d 3 -DHT) and 4 mL methyl-tert-butyl ether (MTBE, Omnisolve®, EMD Milipore, Billerica, MA) in glass screw-top tubes. Calibrators were prepared using 50 µl spiking solution prepared in 75% methanol and added to the extraction tube. Either the entire 1 mL cell pellet suspension was added to the extraction tube and the original container rinsed with 25% methanol in water or samples were volume and compositionally corrected. Tubes were capped with Teflon-lined caps, vortexed, rotated 15 min and centrifuged using a Sorvall model RT6000B centrifuge (Thermo Scientific) at 2,800 rpm and 4°C for 15-30 min to separate liquid phases. The aqueous phase was frozen in a dry ice/acetone bath and MTBE layer was poured into a clean glass conical tube. MTBE was evaporated at 37°C with nitrogen and the residue was reconstituted with 60% methanol. The suspension was centrifuged using Heraeus Multifuge X3R centrifuge (Thermo Scientific) at 2,800 rpm and 4°C for 5 min to separate insoluble materials. An aliquot of the supernatant was injected.
LC-MS/MS analysis of the extracted samples was performed using a Prominence UFLC System (Shimadzu Scientific Instruments, Kyoto, Japan) a QTRAP ® 5500 mass spectrometer (AB Sciex, Framingham, MA) with an electrospray ionization source and two 10-port switching valves (Model EPC10W Valco Instruments Co. Inc., Houston, TX,). The first switching valve was mounted in the column oven and was used to perform inline sample cleanup. The second valve functioned as a divert valve to switch the column eluent between waste and the mass spectrometer. Chromatographic separation was achieved using a Phenomenex ® Luna ® C18(2) column (part number 00F-4251-B0) preceded by a Phenomenex ® SecurityGuard™ cartridge (C18, part number AJ0-4286). The HPLC column was maintained at 60°C and flow rate was 175 µL/min using a biphasic gradient. Mobile phase A was 65% methanol containing 400 µL 1 M ammonium formate and 65 µL concentrated formic acid per liter. Mobile phase B was 100% methanol containing 400 µL 1 M ammonium formate and 65 µL concentrated formic acid per liter.
Analytes were detected using multiple reaction monitoring in positive ion mode controlled by AB SCIEX Analyst ® software, version 1.6.2 (AB Sciex). Mass spectrometer conditions were ion spray voltage 5,250 volts, turbo gas temperature 700 °C, gas 1 = 65, gas 2 = 60, curtain gas = 20, collision-associated dissociation gas medium and unit mass resolution for Q1 and Q3. Nitrogen was used for all gases and voltages for maximum parent/fragment ion pair intensities were optimized using direct infusion and flow injection analysis. Calibration curves were generated using analyte/IS area response ratios versus nominal concentrations (ng/mL) and weighted linear regressions with a weighting factor of 1/concentration.
2 The IS used for T, ASD and DHEA was d 3 -T and d 3 -DHT was used for DHT and AND. Back-calculated concentrations were generated using the formula x = (y -b)/m where x is the back-calculated concentration, y is analyte/IS ratio, b is y-intercept and m is slope.
Calibrator and quality control acceptance criteria required all acceptable concentrations to have accuracy deviations ≤ 15% from the nominal concentration and relative standard deviation criteria (% RSD) ≤ 15%, except at the lower limit of quantitation (LLOQ), listed in Supplementary Table 2 which was allowed 20% deviation for both parameters. Values below the LLOQ (BLQ) were treated as 0. LNCaP cells were transfected with empty, wild-type or Y176F,K180R RDH16, treated with SFM or SFM with dutasteride for 12 h and cell pellet androgen levels were measured using LC-MS/MS. T levels for LNCaP (A) and western blot analysis for DDK tag (B). 5α-dione did not pass standard acceptance criteria during assay validation (i.e., theoretical concentration ± 15% as recommended by FDA's Bioanalytical Guidance), but 5α-dione levels were reported since 5α-dione is an integral component of the androgen pathway under study. Overall performance statistics of the calibrators and quality controls for the nine analytical runs disclosed that six runs passed the normal ±15% criteria, one run passed at ±20%, one run passed at ±25% and one run passed at ±30%. 
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